Cargando…
Transient B Cell Depletion or Improved Transgene Expression by Codon Optimization Promote Tolerance to Factor VIII in Gene Therapy
The major complication in the treatment of hemophilia A is the development of neutralizing antibodies (inhibitors) against factor VIII (FVIII). The current method for eradicating inhibitors, termed immune tolerance induction (ITI), is costly and protracted. Clinical protocols that prevent rather tha...
Autores principales: | Sack, Brandon K., Merchant, Sherin, Markusic, David M., Nathwani, Amit C., Davidoff, Andrew M., Byrne, Barry J., Herzog, Roland W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3359994/ https://www.ncbi.nlm.nih.gov/pubmed/22655063 http://dx.doi.org/10.1371/journal.pone.0037671 |
Ejemplares similares
-
Development of gene transfer for induction of antigen-specific tolerance
por: Sack, Brandon K, et al.
Publicado: (2014) -
Potential for cellular stress response to hepatic factor VIII expression from AAV vector
por: Zolotukhin, Irene, et al.
Publicado: (2016) -
Innovative Approaches for Immune Tolerance to Factor VIII in the Treatment of Hemophilia A
por: Sherman, Alexandra, et al.
Publicado: (2017) -
Tolerance Induction to Cytoplasmic β-Galactosidase by Hepatic AAV Gene Transfer — Implications for Antigen Presentation and Immunotoxicity
por: Martino, Ashley T., et al.
Publicado: (2009) -
Codon optimized Tol2 transposase results in increased transient expression of a crystallin-GFP transgene in zebrafish
por: Mackey, Allison S., et al.
Publicado: (2020)